t-cell depleted hsv-tk engineering donor lymphocytes
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2010 (NCT00914628)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- t-cell depleted hsv-tk engineering donor lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00914628 | Phase 3 | Feb 1, 2010 | MolMed S.p.A., Vita-Salute University of Milano. Italy |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MolMed S.p.A. | For profit | 1 | 1 | 1 | 2010 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1